317 / 1084
Dose escalation in definitive CRT
ART-DECO: Dutch dose escalation trial in patients with locally
irresectable or medically inoperable carcinoma of the
esophageal or GEJ treated with definitive CRT
R
Standard: 50.4 Gy/28 fr + weekly carboplatin/paclitaxel
Experimental: 61.6 Gy/28 fr (SIB boost GTV ) + weekly C/P
oes